Purified anti-AMD1 Antibody, AMD1, W18041A,BioLegend,660851

For use in immunohistochemistry on formalin-fixed paraffin-embedded tissue (IHC-P), it is recommended to perform antigen retrieval using either Citrate Buffer, 10X (Cat. No. 420902) or Tris-EDTA pH 9.0 Antigen Retrieval Buffer (10X) (Cat. No. 422704).It is not recommended using this product in immunocytochemistry (ICC) or intracellular flow cytometry (ICFC).This antibody does not cross react with mouse AMD1 in Western Blot.

Host

Rat

Reactivity

Human

Application

WB - Quality testedIHC-P - Verified

Platform ID

BAB706040462

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-AMD1 Antibody, AMD1, W18041A
Cat. No.660851
HostRat
RRIDAB_3675187 (BioLegend Cat. No. 660851)AB_3675187 (BioLegend Cat. No. 660852)
IsotypeRat IgG2b, κ
ReactivityHuman
ApplicationWB - Quality testedIHC-P - Verified
ClonalityMonoclonal
Clone NumberW18041A
Concentration0.5 mg/mL
TargetAMD1
ImmunogenRecombinant fragment of human AMD1
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

AMD1 (Adenosylmethionine Decarboxylase 1) is an enzyme critical for polyamine biosynthesis, a process vital for cell growth, proliferation, and differentiation. It decarboxylates S-adenosylmethionine (SAM) to form decarboxylated SAM (dcSAM), a crucial step in the synthesis of spermidine and spermine, which plays a key role in stabilizing cellular structures like DNA and RNA.AMD1 maintains normal cell function through polyamine regulation, while its dysregulation is associated with cancer, neurological diseases, and inflammation. In many cancers, such as colon, prostate, and breast cancer, AMD1 is overexpressed. This leads to elevated polyamine levels, promoting rapid cell division, uncontrolled growth, and tumor progression. Given its role in driving tumor growth, AMD1 is viewed as a potential target for cancer therapy. Inhibiting AMD1 may decrease polyamine production, thereby slowing cancer progression.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.